Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega Study.

air pollution metabolomics population-based traffic density

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 17 11 2023
revised: 08 12 2023
accepted: 11 12 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

Exposure to traffic-related air pollution (TRAP) generates oxidative stress, with downstream effects at the metabolic level. Human studies of traffic density and metabolomic markers, however, are rare. The main objective of this study was to evaluate the cross-sectional association between traffic density in the street of residence with oxidative stress and metabolomic profiles measured in a population-based sample from Spain. We also explored in silico the potential biological implications of the findings. Secondarily, we assessed the contribution of oxidative stress to the association between exposure to traffic density and variation in plasma metabolite levels. Traffic density was defined as the average daily traffic volume over an entire year within a buffer of 50 m around the participants' residence. Plasma metabolomic profiles and urine oxidative stress biomarkers were measured in samples from 1181 Hortega Study participants by nuclear magnetic resonance spectroscopy and high-performance liquid chromatography, respectively. Traffic density was associated with 7 (out of 49) plasma metabolites, including amino acids, fatty acids, products of bacterial and energy metabolism and fluid balance metabolites. Regarding urine oxidative stress biomarkers, traffic associations were positive for GSSG/GSH% and negative for MDA. A total of 12 KEGG pathways were linked to traffic-related metabolites. In a protein network from genes included in over-represented pathways and 63 redox-related candidate genes, we observed relevant proteins from the glutathione cycle. GSSG/GSH% and MDA accounted for 14.6% and 12.2% of changes in isobutyrate and the CH

Identifiants

pubmed: 38136241
pii: antiox12122122
doi: 10.3390/antiox12122122
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Laura Sanchez-Rodriguez (L)

Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Joint Research Institute-National School of Health (IMIENS), National Distance Education University, 28029 Madrid, Spain.

Marta Galvez-Fernandez (M)

Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Ayelén Rojas-Benedicto (A)

Joint Research Institute-National School of Health (IMIENS), National Distance Education University, 28029 Madrid, Spain.
Department of Communicable Diseases, National Center for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.
CIBER on Epidemiology and Public Health, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Arce Domingo-Relloso (A)

Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.

Nuria Amigo (N)

Biosfer Teslab, 43201 Reus, Spain.
Department of Basic Medical Sciences, Universidad de Rovira i Virgili, 43007 Tarragona, Spain.

Josep Redon (J)

Institute for Biomedical Research, Hospital Clinic de Valencia (INCLIVA), 46010 Valencia, Spain.

Daniel Monleon (D)

Institute for Biomedical Research, Hospital Clinic de Valencia (INCLIVA), 46010 Valencia, Spain.

Guillermo Saez (G)

Department of Biochemistry and Molecular Biology, Faculty of Medicine and Dentistry, Clinical Analysis Service, Hospital Universitario Dr. Peset-FISABIO, Universitat de Valencia, 46020 Valencia, Spain.

Maria Tellez-Plaza (M)

Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Juan Carlos Martin-Escudero (JC)

Department of Internal Medicine, Hospital Universitario Rio Hortega, University of Valladolid, 47012 Valladolid, Spain.

Rebeca Ramis (R)

Integrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, 28029 Madrid, Spain.
CIBER on Epidemiology and Public Health, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Classifications MeSH